GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » EBIT per Share

Hubei Guangji Pharmaceutical Co (SZSE:000952) EBIT per Share : ¥-0.66 (TTM As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Hubei Guangji Pharmaceutical Co EBIT per Share?

Hubei Guangji Pharmaceutical Co's EBIT per Share for the three months ended in Mar. 2025 was ¥-0.09. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-0.66.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Hubei Guangji Pharmaceutical Co's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Hubei Guangji Pharmaceutical Co was 159.30% per year. The lowest was -61.40% per year. And the median was -15.40% per year.

SZSE:000952's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 8.3
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Hubei Guangji Pharmaceutical Co's EBIT for the three months ended in Mar. 2025 was ¥-30.2 Mil.

Hubei Guangji Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Hubei Guangji Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Guangji Pharmaceutical Co EBIT per Share Chart

Hubei Guangji Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.41 0.23 -0.26 -0.72

Hubei Guangji Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.13 -0.11 -0.12 -0.35 -0.09

Hubei Guangji Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Hubei Guangji Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

EBIT per Share(A: Dec. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=-258.318/359.716
=-0.72

Hubei Guangji Pharmaceutical Co's EBIT per Share for the quarter that ended in Mar. 2025 is calculated as

EBIT per Share(Q: Mar. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-30.238/349.722
=-0.09

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Guangji Pharmaceutical Co  (SZSE:000952) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Hubei Guangji Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Hubei Guangji Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Guangji Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Guangji Pharmaceutical Co Ltd (SZSE:000952) » Definitions » EBIT per Share
Comparable Companies
SHSE:600671 SZSE:000705 SHSE:600613 SZSE:301281 SZSE:001367 SZSE:002198 SZSE:300006 SZSE:301096 SZSE:301507 SHSE:688710 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN PFE
Traded in Other Exchanges
N/A
Address
No. 555, Huaihai West Road, 26th Floor, Xuhui District, Shanghai, CHN, 200030
Website
http://www.guangjipharm.com
Hubei Guangji Pharmaceutical Co Ltd is engaged in the manufacture and sale of raw pharmaceutical products, medicinal feed additives, fine chemicals and preparations in China. Geographically the business activities are carried out through China, however, more than 60 percent of its main products are exported to over 30 countries and regions all over the world.
Executives
Zou Guang Ming Independent director
Guo Shao Zhi Executives
Zhang Bin Director
Guo Wen Chao Supervisors
Sun Zhen Hua Director
Liao Qing Jiang Director
Wang Xin Directors, executives
Hu Feng Lei Supervisors
Ruan Zhong Yi Executives
Zhang Ping Director

Hubei Guangji Pharmaceutical Co Headlines

No Headlines